NASDAQ:SBFM
Sunshine Biopharma, Inc.
- Stock
Last Close
1.79
06/11 21:40
Market Cap
8.06M
Beta: −1.00
Volume Today
73.81K
Avg: 127.64K
PE Ratio
−0.22
PFCF: −0.67
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -1.93M - | -1.65M 14.58% | -3.50M 111.64% | -1.04M 70.25% | -2.16M 107.28% | -1.66M 23.00% | -2.78M 67.69% | -12.44M 346.70% | -26.74M 115.05% | -4.51M 83.15% | |
depreciation and amortization | 4.25K - | 60.73K 1,328.63% | 6.63K 89.08% | 49.36K 644.62% | 13.77K 72.10% | 14.07K 2.12% | 12.74K 9.42% | 25.16K 97.50% | 149.15K 492.72% | ||
deferred income tax | -261.69K - | -50K 80.89% | -918K 1,736% | 3.63K 100.40% | |||||||
stock based compensation | 1.26M - | 261.69K - | 50K 80.89% | 918K 1,736% | -3.63K 100.40% | ||||||
change in working capital | 24.43K - | 75.74K 210.05% | -90.99K 220.13% | -17.26K 81.03% | 54.58K 416.17% | -30.92K 156.65% | -42.64K 37.89% | -108.80K 155.16% | 3.15M 2,999.44% | -4.32M 237.07% | |
accounts receivables | -15.45K - | -430 97.22% | -1.49K 245.58% | -5.88K 295.83% | -524.49K 8,816.80% | -594.14K 13.28% | |||||
inventory | -15.91K - | -7.86K 50.59% | -81.88K 941.59% | 42.98K 152.50% | -2.37M 5,603.45% | ||||||
accounts payables | 10.96K - | 92.31K 742.48% | -18.96K 120.54% | -8.81K 53.54% | 61.63K 799.69% | -18.69K 130.33% | -35.01K 87.31% | -18.16K 48.14% | 3.36M 18,601.55% | -1.36M 140.61% | |
other working capital | 13.47K - | -16.57K 222.98% | -72.03K 334.74% | -8.46K 88.26% | 8.40K 199.36% | 4.11K 51.08% | 1.72K 58.15% | -2.88K 267.44% | 276.87K 9,713.40% | 4.32M 1,461.70% | |
other non cash items | 113.18K - | 704.53K 522.49% | 3.21M 356.01% | 507.35K 84.21% | 1.54M 203.42% | 1.18M 23.24% | 2.16M 82.40% | 10.70M 396.59% | 18.32M 71.13% | -4.42M 124.12% | |
net cash provided by operating activities | -538.60K - | -867.64K 61.09% | -314.18K 63.79% | -543.52K 73.00% | -512.81K 5.65% | -495.80K 3.32% | -657.30K 32.57% | -1.83M 178.28% | -5.25M 186.93% | -8.78M 67.20% | |
investments in property plant and equipment | -623.60K - | -3.44K 99.45% | -3.72K 8.11% | -18.85K 406.99% | -860 95.44% | -1.19K 38.49% | -305.00K - | ||||
acquisitions net | -80.29K - | 4.94K 106.16% | -14.35M - | ||||||||
purchases of investments | |||||||||||
sales maturities of investments | |||||||||||
other investing activites | -14.42K - | 33.38K - | -656.15K 2,065.76% | ||||||||
net cash used for investing activites | -623.60K - | -3.44K 99.45% | -84.01K 2,342.80% | -13.91K 83.44% | -15.28K 9.84% | -1.19K 92.20% | -14.62M - | -656.15K 95.51% | |||
debt repayment | -115K - | -194.18K 68.86% | -53K 72.71% | -106.60K 101.13% | -475.32K 345.90% | -4.00M 740.74% | |||||
common stock issued | 153.33K - | 236.55K 54.27% | 104.13K 55.98% | 63.91K 38.62% | 30.37M - | ||||||
common stock repurchased | -99K - | ||||||||||
dividends paid | |||||||||||
other financing activites | 497.44K - | 1.16M 133.61% | 220.49K 81.03% | 721.79K 227.35% | 721.82K 0.00% | 495.25K 31.39% | 1.71M 246.26% | 3.38M 97.10% | 13.19M 290.33% | 3.43M 74.04% | |
net cash used provided by financing activities | 650.78K - | 1.40M 114.92% | 324.62K 76.79% | 670.71K 106.61% | 527.64K 21.33% | 442.25K 16.18% | 1.61M 263.65% | 2.90M 80.61% | 39.47M 1,258.68% | 3.43M 91.32% | |
effect of forex changes on cash | -346 - | 6.90K 2,094.80% | 6.76K 2.09% | -5.90K 187.24% | -376 93.62% | -20.27K 5,290.43% | 183.91K 1,007.40% | -62.67K 134.08% | |||
net change in cash | 112.18K - | -92.63K 182.57% | 6.66K 107.18% | 50.08K 652.50% | 7.68K 84.66% | -74.72K 1,072.35% | 949.39K 1,370.68% | 1.06M 11.15% | 19.78M 1,774.51% | -5.53M 127.98% | |
cash at beginning of period | 31.24K - | 143.42K 359.10% | 50.80K 64.58% | 57.45K 13.10% | 107.53K 87.17% | 115.22K 7.15% | 40.50K 64.85% | 989.89K 2,344.11% | 2.05M 106.61% | 21.83M 967.22% | |
cash at end of period | 143.42K - | 50.80K 64.58% | 57.45K 13.10% | 107.53K 87.17% | 115.22K 7.15% | 40.50K 64.85% | 989.89K 2,344.11% | 2.05M 106.61% | 21.83M 967.22% | 16.29M 25.35% | |
operating cash flow | -538.60K - | -867.64K 61.09% | -314.18K 63.79% | -543.52K 73.00% | -512.81K 5.65% | -495.80K 3.32% | -657.30K 32.57% | -1.83M 178.28% | -5.25M 186.93% | -8.78M 67.20% | |
capital expenditure | -623.60K - | -3.44K 99.45% | -3.72K 8.11% | -18.85K 406.99% | -860 95.44% | -1.19K 38.49% | -305.00K - | ||||
free cash flow | -538.60K - | -1.49M 176.88% | -317.62K 78.70% | -547.24K 72.29% | -531.66K 2.85% | -496.66K 6.58% | -658.49K 32.58% | -1.83M 177.78% | -5.55M 203.61% | -8.78M 58.01% |
All numbers in USD (except ratios and percentages)